The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Open accessAbstract
We describe the opioid properties of a tridecapeptide, the sequence of which corresponds to the NH2-terminal sequence of dynorphin, a novel porcine pituitary endorphin. It contains [Leu]enkephalin. In the guinea pig ileum longitudinal muscle preparation it is about 700 times more potent than [Leu]enkephalin. Its effects in this tissue are blocked completely by naloxone, but the apparent affinity of naloxone is 1/13th that for blockade of [Leu]enkephalin or normorphine. In the mouse vas deferens, this peptide is 3 times more potent than [Leu]enkephalin. Well-washed rat brain membranes degrade the peptide rapidly, suggesting the presence of a membrane-bound degradative enzyme. The peptide displays considerable immunoreactivity in assays with antisera that have been used for the immunohistochemical localization of [Leu]enkephalin. The remarkable enhancement of the potency of [Leu]enkephalin by the COOH-terminal extension -Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-OH suggests new interpretations concerning the structure of opiate receptors and the function of the enkephalin pentapeptides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This system is comprised of three types of opioid receptors: μ (MOR), δ (DOR), and κ (KOR); and their endogenous ligands, endorphin, enkephalin and dynorphin (Hughes et al 1975; Birdsall and Hulme 1976; Goldstein et al 1979; Evans et al 1992; Kieffer et al 1992; Chen et al 1993; Yasuda et al 1993).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Goldstein et al 1979
Citations
Cites
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
Hunter, W. M., & Greenwood, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,902
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Cox, B. M., Opheim, K. E., Teschemacher, H., & D, A. G. M. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90272-6 · Cited by 1,708
Immunohistochemical localization of enkephalin in rat brain and spinal cord
Sar, M., Stumpf, W. E., Miller, R. J., Chang, K., & Cuatrecasas, P. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901820103 · Cited by 822
Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.
Chang, K. J., & Cuatrecasas, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30115-1 · Cited by 683
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J., & Fong, B. T. W. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
Endogenous and Exogenous Opiate Agonists and Antagonists
(1980) · Elsevier eBooks · doi:10.1016/c2013-0-03337-3 · Cited by 447
Hughes, J. W., Kosterlitz, H. W., & Leslie, F. M. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07373.x · Cited by 405
Hunkapiller, M. W., & Hood, L. (1978) · Biochemistry · doi:10.1021/bi00604a016 · Cited by 383
Self-citationIn Vitro Models in the Study of Structure-Activity Relationships of Narcotic Analgesics
Kosterlitz, H. W., & Waterfield, A. A. (1975) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.15.040175.000333 · Cited by 293
Cited by
Sorted by citations
Items 701–800 of 883
Single-channel observations on the mu-opioid receptor
Smuda, J. W., & de Levie, R. (1986) · Biophysical Journal · doi:10.1016/s0006-3495(86)83516-0 · Cited by 2
ACTIVATION OF OPIOID‐CONTAINING SYSTEMS DURING GESTATION
Gintzler, A. R. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39502.x · Cited by 2
U�da, K., Okamura, H., Imura, H., Yanaihara, C., Yanaihara, N., & Ibata, Y. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90281-2 · Cited by 2
Motivational systems: fear or defense? pain or recuperation?
Adams, D. B. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004921 · Cited by 2
Peptides: Chemistry, Biology, and Pharmacology
Judd, A. K., & Schoolnik, G. K. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60344-0 · Cited by 2
Stress and arousal in pain perception
Appley, M. H. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004933 · Cited by 2
Naloxone produces a fear and pain model
Dubner, R. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004994 · Cited by 1
Bowsher, D. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004969 · Cited by 1
Smith, A. P., & Loh, H. H. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-447210-5.50010-0 · Cited by 2
Lung, F. ‐. T., Collins, N., Li, G., Meyer, J.-P., Lou, B., Stropova, D., Davis, P., Davis, T. P., Porreca, F., Yamamura, H. I., et al. (1995) · Springer eBooks · doi:10.1007/978-94-011-1468-4_289 · Cited by 2
Glembotski, C. C. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-417560-0.50017-9 · Cited by 2
Structure and dynamics of dynorphin peptide and its receptorPreprint
Ferre, G., Czaplicki, G., Demange, P., & Milon, A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1906.11659 · Cited by 2
“The ability to produce dynorphin and analogues by solid-phase peptide synthesis (Goldstein, et al., 1979) opened the way to a wide range of structure-activity relationship studies on various peptide structures.”
BackgroundAnalgesics, Antipyretics, and Antiinflammatory Agents
(2006) · Van Nostrand's Scientific Encyclopedia · doi:10.1002/0471743984.vse7721 · Cited by 2
Descending Modulation of Nociceptive Processing
Dubner, R. A., & Ren, K. (2013) · Springer eBooks · doi:10.1007/978-3-642-28753-4_1066 · Cited by 2
Gustafsson, L. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Endogenous Opioid Peptides, Glucocorticoids, and Shock: Specificity, Site, and Mechanism of Action
van Giersbergen, P. L. M., van den Berg, M. H., Eijgelshoven, M. H. J., Cox, J. J., BERG, D. T. W. M. V. D., de Kloet, E. R., & de Jong, W. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9834-3_11 · Cited by 2
Extrapituitary Functions of Thyrotropin-Releasing Hormone
Hirsch, M. D. (1983) · Springer eBooks · doi:10.1007/978-94-009-6601-7_2 · Cited by 2
ISOLATION OF DYNORPHIN-LIKE PEPTIDE FROM GUT EXTRACT
Tachibana, S., Araki, K., Ohya, S., & Yoshida, S. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50054-1 · Cited by 2
Self-citationDelta opioid receptors affect acoustic features of song during vocal learning in zebra finches
Singh, U. A., & Iyengar, S. (2025) · BMC Neuroscience · doi:10.1186/s12868-025-00927-x · Cited by 1
“Additionally, each endogenous opioid peptide can also act by binding to other types of opioid receptors [10–12].”
Kim, H. (2025) · Psychiatry International · doi:10.3390/psychiatryint6040154 · Cited by 2
“Dynorphins, including dynor-phin A and dynorphin B, are cleaved from prodynorphin and demonstrate particularly high concentrations in the hypothalamus, brainstem, and spinal cord [11].”
Prodynorphin-Derived Opioid Peptides
Spampinato, S. M. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50186-0 · Cited by 1
Tseng, L. F. (2014) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2014.08.001 · Cited by 1
How Does Stress Affect the Immune Response?
Sizemore, R. C. (2012) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000e101 · Cited by 1
“The dynorphins are derived from prodynorphin, also a pituitary hormone [10,11].”
BackgroundIn search of a status for acupuncture.
Roux, A. G. L., Chung, C.-C., & Sim, C. B. (1984) · PubMed · Cited by 1
The neurochemistry of defensive behavior and fear
Miczek, K. A. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00005100 · Cited by 1
Conversation with Avram Goldstein
D, A. G. M. (1997) · Addiction · doi:10.1080/09652149736765 · Cited by 1
Functional Evolution of Opioid Family G Protein-Coupled Receptors
Vardy, E., Stevens, C. W., & Roth, B. L. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-779-2_5 · Cited by 1
Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology
McAnally, H. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47497-7_2 · Cited by 1
Non-Cholinesterase Effects of Anticholinesterases
O’Neill, J. J. (1983) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-69228-4_5 · Cited by 1
Scott, C. E., Pickering, E. V., & Anderson, G. T. (2022) · ACS symposium series · doi:10.1021/bk-2022-1428.ch007 · Cited by 1
Flores‐Ramirez, F. J., Illenberger, J. M., & Martin‐Fardon, R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100695 · Cited by 1
“The peptide DYN (Goldstein et al., 1979), derived from pro-DYN, is the endogenous ligand for and preferentially binds to κ -opioid receptors (KOPs; (Chavkin et al., 1982), although DYN binds to all three opioid receptor subtypes (Schwarzer, 2009).”
Opioid receptors in GtoPdb v.2021.3
Borsodi, A. D., Bruchas, M. R., Calò, G., Chavkin, C., Christie, M. J., Civelli, O., Connor, M. A., Cox, B. M., Devi, L. A., Evans, C. J., et al. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f50/2021.3 · Cited by 1
Positron Emission Tomography (PET) Imaging of Opioid Receptors
van Waarde, A., Absalom, A. R., Visser, A. K. D., & Dierckx, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_21 · Cited by 1
The role of peptides in the brain
Segal, M. B., & Zloković, B. V. (1990) · Springer eBooks · doi:10.1007/978-94-009-2229-7_4 · Cited by 1
Evidence for the involvement of MC4 receptors in the central mechanisms of opioid antinociception
Starowicz, K. (2005) · Utrecht University Repository (Utrecht University) · Cited by 1
Neuroendokrinologische Aspekte der Endorphine
Herz, A. (1980) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-47091-2_3 · Cited by 1
Opioid and non-opioid activities of the dynorphins
Marinova, Z. (2005) · Figshare · Cited by 1
HO, C., & Li, C. H. (1987) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1987.tb02239.x · Cited by 1
Clinical implications of Bolles & Fanselow's pain/fear model
Chapman, C., & Gagliardi, G. J. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004982 · Cited by 714
Contextual determinants of pain reactions
Vierck, C., & Cooper, B. Y. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00005112 · Cited by 1
Methods for Isolation, Characterization, and Sequence Analysis of Enkephalin Precursors
STERN, A. S., & Lewis, R. V. (1985) · Springer eBooks · doi:10.1007/978-1-4615-7760-7_5 · Cited by 1
Neuroendocrinology and Brain Peptides An Emerging New Frontier in Neurobiology
Martin, J. B. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4529-9_2 · Cited by 1
Hewlett, W. A., Barchas, J. D., & Akil, H. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50019-x · Cited by 1
Lindqvist, A. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Recent Studies on Opioid Receptors
Simon, E. J. (1988) · Springer eBooks · doi:10.1007/978-3-642-73172-3_35 · Cited by 1
SIGNALING PATHWAYS INVOLVED IN IL-1BETA- INDUCED REGULATION OF MOR EXPRESSION IN HUMAN NEURONS By
Mohan, S., Hertfordshire, H., & Uk, E. (2008) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Pathogenesis of Motor Response Complications in Parkinson’s Disease
Metman, L. V. (2004) · CRC Press eBooks · doi:10.1201/9780203508596.pt7.d · Cited by 1
Mechanisms of EphB2 Mediated Opiate-dependent Tolerance and Learning
Huroy, S. (2012) · TSpace (University of Toronto) · Cited by 1
Bedenbaugh, M. N. (2018) · doi:10.33915/etd.5174 · Cited by 1
Sakurada, S., & Sakurada, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50188-4 · Cited by 1
Simon, E. J. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4568-8_12 · Cited by 1
Elks, J., & Ganellin, C. R. (1990) · Springer eBooks · doi:10.1007/978-1-4757-2085-3_4 · Cited by 1
Dynorphin-(1–13): Antinociceptive Action and Its Effects on Morphine Analgesia and Acute Tolerance
Kishioka, S., Naonori, M., Kitabata, Y., Tetsuji, Y., Yoshiyuki, M., Masanobu, O., & Yamamoto, H. (1992) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)32410-2 · Cited by 1
Harrison, C., & Lambert, D. G. (2001) · Springer eBooks · doi:10.1007/978-88-470-2903-3_37 · Cited by 1
Hyper-Endorphin Syndrome in Necrotizing Encephalomyelopathy
(1981) · New England Journal of Medicine · doi:10.1056/nejm198102193040816 · Cited by 1
Opiates - Pharmacology of Pain
Porreca, F. (2006) · Springer eBooks · doi:10.1007/978-3-540-29805-2_2935 · Cited by 1
Zusammenfassung: Spinale Schmerzverarbeitung
Waldvogel, H. H. (1996) · Springer eBooks · doi:10.1007/978-3-642-97649-0_5 · Cited by 1
Przewłocki, R., Lasoń, W., Stach, R., Kacz, D., Stala, L., & Przewłocka, B. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50082-6 · Cited by 1
Krömer, W., Schmidt, H., & Höllt, V. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50065-6 · Cited by 1
Behavioural Pharmacology of Novel Kappa Opioid Compounds
Morani, A. S. (2011) · Figshare · doi:10.26686/wgtn.17011409.v1
“The kappa opioid receptors The KOPr is a member of 7 transmembrane G-protein coupled receptor protein (Eguchi, 2004) and the endogenous neuropeptide dynorphin (DYN; Goldstein et al., 1979) binds with high affinity to the KOPr (Corbett et al.”
BackgroundREGIONAL DISTRIBUTION OF IMMUNOREACTIVE “BIG” LEU-ENKEPHALINS IN BRAIN AND PITUITARY
Minamino, N., Hayashi, Y., Kitamura, K., Matsuo, H., & Kangawa, K. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50057-7
Hugonin, L. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Chapter 4. Analgesics, Endorphins, and the Opiate Receptor
Kobylecki, R. J., & Morgan, B. A. (1980) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60365-6
Opiate Receptors and Their Ligands
Simon, E. J. (1983) · Elsevier eBooks · doi:10.1016/b978-0-08-029804-7.50031-7
The Impact of Growth Hormone and Gamma-Hydroxybutyrate (GHB) on Systems Related to Cognition
Johansson, J. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
ANATOMICAL AND BIOCHEMICAL STUDIES OF DYNORPHIN
Watson, S. J., Akil, H., & D, A. G. M. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50058-9
ENDORPHIN MEASUREMENTS IN SCHIZOPHRENIA, A PROGRESS REPORT
Lindström, L., Besev, G., Gunne, L. M., Sjöström, R., Terenius, L. Y., Wahlström, A., & Wistedt, B. (1981) · Elsevier eBooks · doi:10.1016/b978-0-08-026382-3.50047-5
Pharmacology of Intracellular Ca2+
Campbell, A. K. (2014) · doi:10.1002/9781118675410.ch11
Spinal Dynorphin and Neuropathic Pain
Lai, J. Y., Wang, R., & Porreca, F. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_16
EXPRESSION OF THE OPIOID GENES
Civelli, O., Oates, E. L., Rosen, H., Martens, G. J. M., Comb, M. J., DOUGLASS, J. O., & Herbert, E. (1983) · Elsevier eBooks · doi:10.1016/b978-0-12-417320-0.50009-3
Spahn, V. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7050
Magnusson, K. (2009) · Uppsala University Publications (Uppsala University)
How are defensive and recuperative actions produced?
Bindra, D. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004945
Pan, Y.-J., Yin, Z., Yang, J., Zhao, Y. Y., & Wang, D. (2012) · Open Journal of Anesthesiology · doi:10.4236/ojanes.2012.22008
“purified and identified L-Ek and M-Ek in 1975 [5], the endorphin had been confirmed in 1976 [6] and dynorphin in 1979 [7].”
BackgroundB-endorphin and ACTH: inhibitory and excitatory neurohormones of pain and fear?
Jacquet, Y. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00005082
The development of opioid analgesics and fashions in their delivery
VERNER, I. R. (1994) · Current Anaesthesia and Critical Care · doi:10.1016/0953-7112(94)90033-7
Valenzuela, R. F., Tachibana, S., & Huidobro-Toro, J. P. (1991) · Peptides · doi:10.1016/0196-9781(91)90196-v
Self-citationRECENT ADVANCES IN OPIOID PHARMACOLOGY
Livingston, A. (1985) · Journal of the Association of Veterinary Anaesthetists of Great Britain and Ireland · doi:10.1111/j.1467-2995.1985.tb00048.x
DYNORPHIN: DIFFERENTIAL INTERACTIONS WITH OPIATES AND PEPTIDES IN NAIVE AND MORPHINE TOLERANT MICE
Tulunay, F. C., Jen, M.-F., & Lee, N. M. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50097-8
EFFECTS OF JOINT COCAINE AND ETHANOL ON THE BRAIN OPIOID SYSTEMS
Rosin, Å. (2005) · Figshare
Design, Synthesis and Evaluation of Peptide-Based Affinity Labels for Mu Opioid Receptors
Sinha, B. (2009) · KU ScholarWorks (University of Kansas)
Concerted Dd NMR And Molecular Dynamics Study Of Dynorphin A (1-17)
Prabhakaran, M., Huang, S.-G., & Renugopalakrishnan, V. (2005) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.1990.691929
Nguyen, X. V. (2007) · UKnowledge (University of Kentucky)
The explanation of motivation and the motivation of explanation
Catania, A. C. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004970
THE CONTRIBUTION OF DESCENDING PAIN FACILITATION TO THE MAINTENANCE OF NEUROPATHIC PAIN
Gardell, S. E. (2003) · UA Campus Repository (The University of Arizona)
Differential Regulation of Opioid Receptors During Inflammation
Satterfield, C. S. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Expression of Opioid Peptide Genes in Different Species
Herbert, E., Comb, M. J., Rosen, H., & Martens, G. J. M. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2717-2_18
Bradykinin Ligands and Receptors Involved in Neuropathic Pain
Hall, S. M. (2015) · UA Campus Repository (The University of Arizona)
Wiese, U. H. (1987) · Advances in neurosurgery · doi:10.1007/978-3-642-71793-2_57
Toward a Conjunction of Biomedical and Behavioral Sciences
Hamburg, D. A. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-532102-0.50005-x
Le sport peut-il devenir une drogue ?
Diederichs, A. (2015) · HAL
Molecular mechanisms by which salvinorin A binds to and activates the κ-opioid receptor.
Yan, F. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Participation of the endogenous opioid and cannabinoid systems in neuropathic pain
Roura, N. I., & Xavier (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Halstrøm, J., Qasim, M. A., Brunfeldt, K., & Nebelin, E. (1981) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1981.362.1.593
Fear and pain: semantic, biochemical and clinical reflections
Eichelman, B. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00005008
Opioid-Mediated Control of Neuroendocrine Function
Cicero, T. J., & Adams, M. L. (1995) · Humana Press eBooks · doi:10.1007/978-1-4612-0243-1_2
Metadata
- Authors
- Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L.
- Affiliations
- California Institute of Technology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1979-12
- Volume
- 76
- Issue
- 12
- Pages
- 6666-6670
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC411929
- OpenAlex
- W2033680879
- Cited by
- 882
- References
- 18
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 14 · 2022: 10 · 2021: 14 · 2020: 23 · 2019: 13 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 16 · 2013: 23 · 2012: 18
- FWCI
- 24.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- dynorphin A(1-13), opioid peptides, leu-enkephalin, enkephalin, naloxone, opioid receptors, vas deferens, peptide degradation, immunoreactivity
- MeSH terms
- Amino Acid Sequence, Animals, Biological Assay, Dose-Response Relationship, Drug, Endorphins, Guinea Pigs, Ileum, Radioligand Assay, Receptors, Opioid, Structure-Activity Relationship, Swine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review